AI

Hereafter: conversations in the afterlife

We speak to Dadbot creator James Vlahos about using conversational AI to better remember loved ones who have passed away; a very interesting step...

VR and AI used to generate structures to attack Coronavirus

Virtual reality and artificial intelligence come together to generate new chemicals from scratch which could be used against SARS-CoV-2. A new paper has outlined...

Longevity and the Singularity

Consciousness in the cloud? Where science fact and fiction collide. While the principle focus of Longevity is undoubtedly the extension of healthy human lifespan, there...

Longevity Leaders World Congress goes virtual

Annual Longevity conference gets a digital makeover as the community adapts to COVID-19. With much of the world still in some form of lockdown, the...

Making the Longevity grade: expanded list of 1000 leading names

2020 list showcases a growing network of Longevity influencers from the worlds of aging research, technology, policy, media and investment. Who's who in Longevity? Following-on...

Applying theoretical physics to Longevity drug discovery

Peter Fedichev's Gero raising $10 million for anti-aging drug discovery and clinical trials. The use of AI in Longevity drug discovery is nothing new, Insilico...

Google on the rise! Yeast is key to Longevity research

It's common knowledge that experiments on mice or pigs, could hold the key to developments in the aging sphere. But, how about yeast? Google...

New data analytics platform in fight against Covid-19

A new analytics platform aggregates data about the latest med tech developments in the fight against Covid-19. The arrival of Covid-19 has brought with it...

Longevity2020: Day 3 recap

Experts, innovators, investors and the curious meet online in the biggest Longevity conference ever staged. As we enter the fourth day of Longevity2020, we thought...

Margaretta Colangelo on Longevity2020

An in-depth preview of big-hitting AI speakers at the first ever online Longevity conference. It's finally here - Longevity2020 week has arrived! Later today, we...

Longevity in a post-COVID world

Longevity International’s Tina Woods discusses what we can learn from the pandemic and how data can help us do better in future. Longevity is about...

The quest to define biological age

Prof Steve Horvath, the founder of epigenetic age measurement, talks methylation clocks and the need for standardisation. A key speaker on the subject will be...

Insilico teams up with Boehringer Ingelheim on drug discovery

Research collaboration to apply generative AI system for discovery of potential therapeutic targets. Artificial intelligence company Insilico Medicine has announced a research collaboration with pharmaceutical...

AI, COVID-19 and aging: this time it’s personal

Dr Richard Siow talks COVID-19, its implications for Longevity, and how AI can play a role. Scientists across the world are scrambling in response to...

Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest. We're moving fast! Longevity 2020 started just over...

Call for consensus in defining biological aging

We speak with a key contributor to the Longevity2020 online conference about biological aging. UK start-up AgeCurve is focused on the measurement of aging and...

Low-dose rapamycin to protect elderly from COVID-19

Longevity researcher proposes clinical trials for low-dose rapamycin (and other geroprotectors) to protect the elderly from COVID-19. The UK's Biogerontology Research Foundation today announced the...

Biological and artificial neurons linked using standard IP

A world wide web that is partly biological has been created around the globe by collaborating scientists. New nanoelectronic device research has enabled both artificial and...

From machines to animals to humans

Exclusive with Prof Joao Pedro de Magalhaes: talking AI, indication expansion and animal models. “Will you still need me, will you still feed me, when...

Some good news: announcing Longevity2020

In these challenging times, with everyone working from home and conferences pushed-back to later this year, we had an idea: Longevity2020 While the world overcomes...

Latest articles

Building an artificial immune system

DoD-funded ThirdLaw Technologies to harness the power of ‘spiroligomers’ to rapidly build new small molecules for Longevity therapies. Far from the world of stock market...

Neurotech is the new blue ocean

Alon Braun, Co-Founder, Neurotech Analytics.

Amazon and K4Connect demonstrate scalability for agetech

Covid-19 has been difficult for everyone, but particularly for people over the age of 65 who may spend months shut away from loved ones...

“Avoid the use of DQ as a senolytic therapy”

Forever Healthy Foundation issues risk-benefit analysis on dasatinib + quercetin as a senolytic. The Forever Healthy Foundation today published its latest risk-benefit analysis, which explores...